JMP Securities reiterated their market outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report published on Friday, Benzinga reports. They currently have a $29.00 price target on the biotechnology company’s stock. Other equities research analysts also recently issued research reports about the stock. Royal Bank of Canada upped their price target […]

Macquarie reiterated their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. Macquarie currently has a $139.00 target price on the stock. Several other research analysts also recently weighed in on the company. KeyCorp began coverage on Addus HomeCare in a […]

Evolent Health (NYSE:EVH – Get Free Report) was upgraded by equities research analysts at KeyCorp to a “strong-buy” rating in a research report issued on Thursday, Zacks.com reports. Several other equities research analysts have also recently weighed in on EVH. Royal Bank of Canada reiterated an “outperform” rating and set a $42.00 price target on […]

HC Wainwright reaffirmed their neutral rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $25.00 price target on the biopharmaceutical company’s stock. Other equities research analysts also recently issued reports about the company. Scotiabank dropped their target price on Sage […]

Piper Sandler restated their overweight rating on shares of PROCEPT BioRobotics (NASDAQ:PRCT – Free Report) in a research report released on Tuesday morning, Benzinga reports. The firm currently has a $75.00 target price on the stock. PRCT has been the subject of a number of other research reports. TD Cowen lifted their price objective on […]

Royal Bank of Canada reiterated their outperform rating on shares of Evolent Health (NYSE:EVH – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $42.00 target price on the technology company’s stock. Several other brokerages have also recently issued reports on EVH. JMP Securities dropped their price objective on shares […]

DRI Healthcare Trust (TSE:DHT.UN – Free Report) had its target price raised by Scotiabank from C$21.00 to C$22.00 in a report issued on Tuesday morning, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock. A number of other analysts have also recently commented on DHT.UN. CIBC reduced their price target on DRI […]

Redburn Atlantic started coverage on shares of Legend Biotech (NASDAQ:LEGN – Free Report) in a report published on Tuesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $86.00 target price on the stock. Several other equities research analysts have also recently issued reports on the stock. TD Cowen lowered their price objective […]

BTIG Research upgraded shares of Affirm (NASDAQ:AFRM – Free Report) from a neutral rating to a buy rating in a report released on Tuesday, Marketbeat reports. The brokerage currently has $68.00 price target on the stock. Several other analysts have also issued reports on AFRM. JPMorgan Chase & Co. increased their target price on Affirm […]

Eli Lilly and Company (NYSE:LLY – Free Report) had its target price raised by Truist Financial from $1,000.00 to $1,033.00 in a report published on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. LLY has been the subject of a number of other research reports. Morgan Stanley restated an […]

Raymond James reaffirmed their outperform rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a report released on Thursday morning, MarketBeat.com reports. Raymond James currently has a $155.00 price target on the stock. Other equities analysts also recently issued reports about the company. Royal Bank of Canada cut their price objective on Neurocrine […]

Cantor Fitzgerald reissued their overweight rating on shares of DoorDash (NASDAQ:DASH – Free Report) in a research report report published on Monday morning, Benzinga reports. The firm currently has a $160.00 price objective on the stock. A number of other equities analysts also recently issued reports on DASH. Benchmark reissued a buy rating and set […]

Health Catalyst (NASDAQ:HCAT – Free Report) had its price objective hoisted by Evercore ISI from $8.00 to $10.00 in a report published on Tuesday morning, Benzinga reports. The firm currently has an outperform rating on the stock. Several other research analysts also recently issued reports on HCAT. Piper Sandler cut their price objective on Health […]

Morgan Stanley lowered shares of Garmin (NYSE:GRMN – Free Report) from an equal weight rating to an underweight rating in a research report sent to investors on Monday, MarketBeat reports. They currently have $138.00 target price on the scientific and technical instruments company’s stock, down from their prior target price of $155.00. Several other research […]

Integra LifeSciences (NASDAQ:IART – Free Report) had its price target reduced by Bank of America from $26.00 to $18.00 in a research report sent to investors on Monday, Benzinga reports. They currently have an underperform rating on the life sciences company’s stock. IART has been the subject of several other research reports. Truist Financial reduced […]

Piper Sandler reiterated their overweight rating on shares of PROCEPT BioRobotics (NASDAQ:PRCT – Free Report) in a report released on Tuesday morning, Benzinga reports. They currently have a $75.00 price objective on the stock. PRCT has been the subject of several other reports. Wells Fargo & Company boosted their target price on shares of PROCEPT […]